Al18F-NOTA-octreotide: first comparison with 68Ga-DOTATATE in a neuroendocrine tumour patient

被引：0
|
作者：
Elin Pauwels
Frederik Cleeren
Térence Tshibangu
Michel Koole
Kim Serdons
Jeroen Dekervel
Eric Van Cutsem
Chris Verslype
Koen Van Laere
Guy Bormans
Christophe M. Deroose
机构：
[1] University Hospitals Leuven,Nuclear Medicine
[2] KU Leuven,Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology
[3] KU Leuven,Radiopharmaceutical Research, Department of Pharmacy and Pharmacology
[4] University Hospitals Leuven,Digestive Oncology
[5] UZ Leuven,Nucleaire Geneeskunde, Campus Gasthuisberg
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2398 / 2399
页数：1
相关论文
共 50 条
  • [21] Comparison of sensitivity of 68Ga-DOTATATE PET/CT and 111In-Octreotide SPECT in somatostatin positive neuroendocrine tumors
    Kumar, Meena
    Broline, Shelly
    Amerinia, Reza
    Thamake, Sanjay
    Ranganathan, David
    Tworowska, Izabela
    Delpassand, Ebrahim
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [22] Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
    Panagiotidis, Emmanouil
    Alshammari, Alshaima
    Miehopoulou, Sofia
    Skoura, Evangelia
    Naik, Keval
    Maragkoudakis, Emmanouil
    Mohmaduvesh, Mullan
    Al-Harbi, Mohammed
    Belda, Maria
    Caplin, Martyn E.
    Toumpanakis, Christos
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) : 91 - 96
  • [23] A prospective head-to-head comparison of 68Ga-NOTA-3P-TATE-RGD and 68Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours
    Jiang, Yuanyuan
    Liu, Qingxing
    Wang, Guochang
    Sui, Huimin
    Wang, Rongxi
    Wang, Jiarou
    Zhu, Zhaohui
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (12) : 4218 - 4227
  • [24] Comparison of 68Ga-DOTATATE (Ga) PET/CT With 111In-Octreotide (Octreoscan) SPECT in Somatastatin Positive Neuroendocrine Tumors (NET)
    Kumar, Meena
    Broline, Shelly
    Amerinia, Reza
    Delpassand, Ebrahim
    PANCREAS, 2014, 43 (03) : 498 - 498
  • [25] Comparison of 68Ga-DOTATATE PET/CT and 68GaDOTATATE PET/MR in Detection of Neuroendocrine Tumour Liver Metastasis
    Demir, B.
    Soydal, C.
    Araz, M.
    Baltacioglu, M. H.
    Oz, D. Kuru
    Kucuk, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S515 - S515
  • [26] Surgical treatment of primary hepatic neuroendocrine tumor diagnosed by Al18F-NOTA-Octreotide PET/CT: a case report
    Zhang, Zhongyan
    Li, Hehe
    FRONTIERS IN MEDICINE, 2023, 10
  • [27] Heterogeneous Uptake of 68Ga-DOTATATE and 18F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients
    Zhou, Yi
    Li, Li
    Wang, Hui
    Huang, He-xiao
    Cao, Dan
    Ke, Neng-wen
    Su, Ming-gang
    Tian, Rong
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 516 - 520
  • [28] 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor
    Acar, Emine
    Kaya, Gamze Capa
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : 53 - 54
  • [29] Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient
    Jullien, Marine
    Reichert, Thibault
    D'Anella, Pascal
    Castinetti, Frederic
    Barlier, Anne
    Brue, Thierry
    Taieb, David
    Cuny, Thomas
    ANNALES D ENDOCRINOLOGIE, 2020, 81 (01) : 39 - 43
  • [30] FDA Approves 18F-Fluciclovine and 68Ga-DOTATATE Products
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 9N - 9N
12345